Pharmaceutical company Merck in Whitehouse Station announced on May 6 it has sold its consumer care line, including the Dr. Scholl’s and Claritin brands, to Bayer AG, a health-care company in Leverkusen, Germany, for $14 billion. Merck is advised by a team from Morgan, Lewis & Bockius in Princeton, led by attorneys David Glazer, Alan Leeds and Randall Sunberg, and groups from Fried, Frank, Harris, Shriver & Jacobson in New York City and Cleary Gottlieb Steen & Hamilton in Brussels. Bayer is advised by Matthew Hurd of New York City’s Sullivan & Cromwell, as well as by teams from Jones Day in Washington, D.C., Allen & Overy in Frankfurt, and Stuttgart-based firm Gleiss Lutz.
$58M Buy for Medicines Co.
Tenaxis Medical Inc., a surgical sealant manufacturer in Mountain View, Calif., announced on April 23 its sale to The Medicines Co. a pharmaceutical company in Parsippany, for $58 million plus up to $112 million in profit-related payments.
